Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis

被引:191
|
作者
Gao, YK
Herndon, JM
Zhang, H
Griffith, TS
Ferguson, TA
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 188卷 / 05期
关键词
apoptosis; inflammation; immune privilege; FasL; interleukin-10;
D O I
10.1084/jem.188.5.887
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Apoptosis is critical to homeostasis of multicellular organisms. In immune privileged sites such as the eye, CD95 ligand (FasL)-induced apoptosis controls dangerous inflammatory reactions that can cause blindness. Recently, we demonstrated that apoptotic cell death of inflammatory cells was a prerequisite for the induction of immune deviation after antigen presentation in the eye. In this report, we examine the mechanism by which this takes place. Our results show that Fas-mediated apoptosis of lymphoid cells leads to rapid production of interleukin (IL)-10 in these cells. The apoptotic cells containing IL-10 are responsible for the activation of immune deviation through interaction with antigen-presenting cells (APC). In support of this, we found that apoptotic cells from IL-10(+/+) animals fed to APC in vitro promote Th2 cell differentiation, whereas apoptotic IL-10(-/-) cells, as well as nonapoptotic cells, favor Th1 induction. Thus, apoptotic cell death and tolerance are linked through the production of an antiinflammatory cytokine to prevent dangerous and unwanted immune responses that might compromise organ integrity.
引用
收藏
页码:887 / 896
页数:10
相关论文
共 50 条
  • [41] Deregulated expression of death receptor Fas (CD95) and its ligand FasL in lung carcinoma
    Brambilla, E
    Lantuejoul, S
    Veyrenc, S
    Brambilla, C
    Viard-Leveugle, I
    LABORATORY INVESTIGATION, 2002, 82 (01) : 316A - 316A
  • [42] Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma
    Gross, N
    Balmas, K
    Brognara, CB
    Tschopp, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (01): : 111 - 114
  • [43] Deregulated expression of death receptor Fas (CD95) and its ligand FasL in lung carcinoma
    Brambilla, E
    Lantuejoul, S
    Veyrenc, S
    Brambilla, C
    Viard-Leveugle, I
    MODERN PATHOLOGY, 2002, 15 (01) : 316A - 316A
  • [44] CD95 ligand in graft rejection
    Nature, 6567 (682):
  • [45] Localization and expression of Fas (CD95) ligand (FasL) and Fas receptor (Fas) in the rat epididymis
    Griffin, FC
    Lowe, DA
    Lund, T
    Cameron, DF
    FASEB JOURNAL, 1997, 11 (03): : 3569 - 3569
  • [46] Regulation of CD95 (Fas)-induced apoptosis in human chondrocytes
    Kuhn, K
    Hashimoto, S
    Lotz, M
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 330A - 330A
  • [47] Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation
    Shatnyeva, Olga M.
    Kubarenko, Andriy V.
    Weber, Claudia E. M.
    Pappa, Alexander
    Schwartz-Albiez, Reinhard
    Weber, Alexander N. R.
    Krammer, Peter H.
    Lavrik, Inna N.
    PLOS ONE, 2011, 6 (05):
  • [48] The CD95 receptor: Apoptosis revisited
    Peter, Marcus E.
    Budd, Ralph C.
    Desbarats, Julie
    Hedrick, Stephen M.
    Hueber, Anne-Odile
    Newell, M. Karen
    Owen, Laurie B.
    Tschopp, Juerg
    Wajant, Harald
    Wallach, David
    Wiltrout, Robert H.
    Zornig, Martin
    Lynch, David H.
    CELL, 2007, 129 (03) : 447 - 450
  • [49] Functional CD95 Ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells
    Fulda, S
    Strauss, G
    Meyer, E
    Debatin, KM
    BLOOD, 2000, 95 (01) : 301 - 308
  • [50] Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction
    Riffkin, CD
    Gray, AZ
    Hawkins, CJ
    Chow, CW
    Ashley, DM
    NEURO-ONCOLOGY, 2001, 3 (04) : 229 - 240